Updates on Epigenetics of Brain Tumor
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Pathophysiology".
Deadline for manuscript submissions: closed (30 November 2024) | Viewed by 1414
Special Issue Editor
2. Health Research Institute of Asturias (ISPA), 33011 Oviedo, Spain
Interests: epigenomics; cancer; aging; proteomics; chromatin signatures; biomarkers; precision medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Primary malignant brain tumors can affect people of any age, including children, and are usually highly aggressive as well as heterogeneous cancers. Currently, epigenetic alterations are a well-established hallmark of these cancers, though there is still a critical need to gain a deeper understanding of their specific roles during tumorigenesis. This Special Issue, dedicated to the epigenetics of malignant brain tumors, with a special focus on glioblastoma multiforme, will highlight the causes and functional consequences of a dysregulated epigenetic landscape in these frequently fatal cancers, covering both basic and more clinical aspects. Original experimental and clinical studies, as well as reviews, studying the plethora of altered epigenetic mechanisms (such as DNA methylation/hydroxymethylation and histone post-translational modifications) in cancerous brain tumors are invited. Finally, how epigenetic players could represent clinical targets, in addition to how their modulation could inform novel therapeutic strategies, and future challenges to overcome for spurring their translation into clinical oncology will also be discussed.
Dr. Virginia López Martínez
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- epigenetics
- glioma
- omics analyses
- 5-hydroxymethylcytosine
- DNA methylation
- histones
- chromatin signatures
- biomarkers
- precision medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
